Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma, Capillary 2Weight Loss 1Spinal Cord Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hemangioma 1Cachexia 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Olanzapine 3Ibuprofen 3Blood Specimen Collection 3anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1dermcidin 1clazakizumab 1bermekimab 1alkaloid GB18 1Vitamin D 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cachexia × Atenolol × Clear all
NCT00625742 2016-02-12

Multimodal Treatment Strategy for Cancer Cachexia

M.D. Anderson Cancer Center

Phase NA Terminated
15 enrolled 4 charts

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡